Sandoz Canada Aims For 10 Biosimilar Launches In Next Decade

Pegfilgrastim And Rituximab Biosimilars Coming Soon

 
• By Dean Rudge
  
Interview_2020_2
Sandoz Canada is gearing up to launch its first oncology biosimilars • Source: Informa
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products